A webinar on “Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator” is taking place on Tuesday, August 11, 10:30-11:30am ET as part of DIA NOW. DIA NOW is a comprehensive, personalized resource for trends and updates on a wide variety of critical issues in the Life Sciences arena. Webinar attendees can take advantage of a one-month free trial of DIA NOW, with searchable, interactive access to session recordings, peer-reviewed journal articles, podcasts, among other resources. Members of DIA NOW can access recorded sessions from the more than 60 global meetings taking place around the world annually and receive breaking news and analysis from DIA’s publishing group.
Register for the webinar here.
Learn more about DIA NOW here.
The U.S. Food and Drug Administration (FDA) is harnessing real-world data to help inform the agency’s overall response to the COVID-19 public health emergency. Two Evidence Accelerator projects have been launched: the COVID-19 Diagnostics Evidence Accelerator and the Therapeutic Evidence Accelerator. The Diagnostics Evidence Accelerator is a multi-stakeholder collaborative project to advance the development of diagnostics, and is organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research. The Diagnostics Evidence Accelerator is the companion project to the previously announced Therapeutic Evidence Accelerator which brings together leading experts in health data aggregation and analytics in a unified, collaborative effort to share insights, compare results and answer key questions to inform the collective COVID-19 response.